STAAR Surgical reported $15.9 million in total revenue for the second quarter, with a net loss of $491,000, according to a company press release.
STAAR reported net income of $861,000 in the same quarter last year, the release said.
“Our nine consecutive quarters of year-over-year growth was interrupted during the second quarter due to the unusual combination of three sales limiting dynamics,” Barry Caldwell, president and CEO of STAAR, said in the release. “The shortfall to revenue expectations was about $2 million.”
Revenue shortfalls were attributed to a flattening of refractive procedures in China, the timing of a stocking order from STAAR’s Korean distributor and a planned transition to a direct-selling model for the Visian ICL in Spain, Caldwell said.
Sales of the Visian ICL grew 4% to $8.6 million, while IOL sales decreased 4% to $6.8 million, the release said.